Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-026425

EVP & Chief Medical Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rangwala Reshma · EVP & Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-29 Grant or award : show line 1 in the form +65,000 65,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-29 Grant or award : show line 2 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…